# Post-Market Clinical Follow-Up of the CT3 Series Continuous Glucose Monitoring System: A 14-Day Observational Study Assessing Accuracy, Safety, and Glucose Control in Patients With Type 1 and Type 2 Diabetes Mellitus

> **NCT07122180** · — · ENROLLING_BY_INVITATION · sponsor: **MDCECRO LLC** · enrollment: 72 (estimated)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DEVICE:** CT3 Series Continuous Glucose Monitoring System:

## Key facts

- **NCT ID:** NCT07122180
- **Lead sponsor:** MDCECRO LLC
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-06-04
- **Primary completion:** 2025-09-17
- **Final completion:** 2026-01-31
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07122180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07122180, "Post-Market Clinical Follow-Up of the CT3 Series Continuous Glucose Monitoring System: A 14-Day Observational Study Assessing Accuracy, Safety, and Glucose Control in Patients With Type 1 and Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07122180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*